Deep, qualified upcoming-era sequencing has uncovered that subclonal mutations (i.e., These existing in just a portion of tumor cells) is usually detected for all driver genes and are connected to rapid illness development and poor outcome.11–thirteen This is especially pertinent for TP53 muta